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Background: Th e involvement of immune mecha-
nism in psychiatric disorders was proposed in macro-
phage theories of depression and schizophrenia. Later, 
the involvement of the infl ammatory related changes 
beyond the cytokines including the interaction be-
tween infl ammatory response system and neuroactive 
tryptophan metabolites that brought imbalance in 
neuroprotective kynurenic acid arm and neurodegen-
erative 3-hydroxykynurenine and quinolinic acid arm 
of the tryptophan catabolic pathway was proposed in 
neuro-degeneration hypothesis of depression. 
Method: A series of studies on human plasma and 
CSF changes and their associations to clinical symp-
toms and response to treatment and certain SNPs of 
genes from the related enzymes were carried out. 
Results: It was observed that the neuroprotective, 
kynurenic acid was signifi cantly lower and one of the 
neurodegenerative metabolites 3-hydroxykynurenine 
was higher in the plasma of drug naïve depressed pa-
tients. Th e plasma kynurenic acid concentration and 
neuroprotective ratio (kynurenic acid/kynurenine) 
gave clear discrimination between the patients and 
controls with reasonable sensitivity and the specifi city. 
Th e CSF fi ndings showed similar direction. Th e fi nd-
ings were also supported by the fi ndings from SNPs 
polymorphism of kynurenine amonitransferase III en-
zyme which indicated the signifi cant association with 
a haplotype and depressive symptoms in combination 
with anxiety in both unipolar and bipolar depression.
Conclusion: Th e major depressive disorder is as-
sociated with imbalanced immune-metabolic-neuro-
chemical systems.
